Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth.
Fesiuk A, Pölöske D, de Araujo ED, Frere GA, Wright TB, Tin G, Raouf YS, Olaoye OO, Park JS, Blavet N, Tichý B, Schlederer M, Högler S, Wolf M, Philippe C, Aksoy O, Varady A, Mata AM, Varenicja M, Szabó B, Weiss T, Wasinger G, Redmer T, Neubauer HA, Susani M, Spielvogel CP, Ning J, Dahlhoff M, Schepelmann M, Kennedy R, Moriggl R, Brown G, Persson J, Gerner C, Bystry V, Hollóczki O, Heery DM, Gunning PT, Merkel O, Hantusch B, Kenner L.
Fesiuk A, et al. Among authors: frere ga.
Mol Cancer. 2025 Oct 14;24(1):256. doi: 10.1186/s12943-025-02451-2.
Mol Cancer. 2025.
PMID: 41088246
Free PMC article.